Physician

Rasa Lilija Buntinas, MD

According to 2025 Medicare claims, Rasa Buntinas, MD (NPI: 1902880966) practices hematology/oncology in the Cedar Rapids, IA market, with the plurality of this provider's patient population coming from Linn, IA. This provider's primary affiliated billing organization is PHYSICIANS' CLINIC OF IOWA, PC (NPI: 1821075599; TIN: 421462899) and primary practice location at 52403-2414. Buntinas is affiliated with the UnityPoint Accountable Care, L.C. (ACO ID: A5170), Aledade 155 National MSSP (ACO ID: A5358), Main Street Rural Health Willow ACO LLC (ACO ID: A5404), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Buntinas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 504 traditional Medicare patients, billed 222,011 HCPCS/CPT codes, and received $3,375,763 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,247 prescription claims across 368 beneficiaries totaling $2,067,266 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 18 claims. Open Payments data shows 14 records totaling $10,253. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,059,303 to $3,375,763. Similarly, Part D prescription costs have moved sharply higher in recent years, from $707,450 to $2,067,266. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.4M2015 Medicare payment: $1,059,303 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,432,076 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,964,314 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,504,835 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,763,827 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,478,886 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,995,005 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,304,413 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,690,783 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,375,763 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201531173,122$1,059,303
2016373126,497$1,432,076
2017386159,920$1,964,314
2018450179,160$2,504,835
2019423193,560$2,763,827
2020422193,452$2,478,886
2021417205,188$2,995,005
2022442179,083$2,304,413
2023451198,735$2,690,783
2024504222,011$3,375,763

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1M$2.1M2015 Drug cost: $707,450 (USD; Tot_Drug_Cst)2016 Drug cost: $1,121,691 (USD; Tot_Drug_Cst)2017 Drug cost: $962,520 (USD; Tot_Drug_Cst)2018 Drug cost: $1,034,920 (USD; Tot_Drug_Cst)2019 Drug cost: $1,004,216 (USD; Tot_Drug_Cst)2020 Drug cost: $1,255,262 (USD; Tot_Drug_Cst)2021 Drug cost: $1,718,572 (USD; Tot_Drug_Cst)2022 Drug cost: $1,981,955 (USD; Tot_Drug_Cst)2023 Drug cost: $2,142,034 (USD; Tot_Drug_Cst)2024 Drug cost: $2,067,266 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151601,030$707,450
20162051,440$1,121,691
20172431,576$962,520
20182801,807$1,034,920
20192911,969$1,004,216
20203091,954$1,255,262
20213352,077$1,718,572
20223422,060$1,981,955
20233642,326$2,142,034
20243682,247$2,067,266

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.8K$7.5K2015 Medicare payment: $998 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $1,693 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $7,518 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $7,529 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $5,890 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,708 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,682 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,454 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $901 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,434 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R14$998
20161528$1,693
20171575$7,518
20181261$7,529
2019N/R89$5,890
20201246$2,708
20211549$3,682
20221618$1,454
2023N/R11$901
20241518$1,434

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4351,395$96
82306Vitamin d-3 level227293$29
80053Blood test, comprehensive group of blood chemicals3891,658$10
36415Insertion of needle into vein for collection of blood sample3821,237$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3901,663$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ImbruvicaIbrutinib31892$501,343
LenalidomideLenalidomide30840$312,490
KisqaliRibociclib Succinate15420$250,236
JakafiRuxolitinib Phosphate11330$192,741
CalquenceAcalabrutinib Maleate12360$174,832

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
L8000Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any typeN1518$1,434

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.13$253Aveo Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.1$10,000PFIZER INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rasa Lilija Buntinas, MD?

Tedicare shows public-source Medicare data for Rasa Lilija Buntinas, MD (NPI 1902880966), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rasa Lilija Buntinas, MD have ACO affiliation data?

Rasa Lilija Buntinas, MD is shown with ACO affiliation data for UnityPoint Accountable Care, L.C. (MSSP, ACO ID A5170), Aledade 155 National MSSP (MSSP, ACO ID A5358), Main Street Rural Health Willow ACO LLC (MSSP, ACO ID A5404), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Rasa Lilija Buntinas, MD?

Rasa Lilija Buntinas, MD is linked to PHYSICIANS' CLINIC OF IOWA, PC (billing NPI 1821075599) in the available physician profile data.

Does Rasa Lilija Buntinas, MD have Open Payments data?

Rasa Lilija Buntinas, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.